Bouke P. C. Hazenberg

9.9k total citations · 1 hit paper
118 papers, 4.6k citations indexed

About

Bouke P. C. Hazenberg is a scholar working on Molecular Biology, Nephrology and Genetics. According to data from OpenAlex, Bouke P. C. Hazenberg has authored 118 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 25 papers in Nephrology and 22 papers in Genetics. Recurrent topics in Bouke P. C. Hazenberg's work include Amyloidosis: Diagnosis, Treatment, Outcomes (88 papers), Parathyroid Disorders and Treatments (22 papers) and Dermatological and Skeletal Disorders (18 papers). Bouke P. C. Hazenberg is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (88 papers), Parathyroid Disorders and Treatments (22 papers) and Dermatological and Skeletal Disorders (18 papers). Bouke P. C. Hazenberg collaborates with scholars based in Netherlands, United States and Germany. Bouke P. C. Hazenberg's co-authors include Johan Bijzet, M. H. van Rijswijk, Philip N. Hawkins, Giampaolo Merlini, Morie A. Gertz, G Grateau, Pierre Ronco, Ray Comenzo, Jean Paul Fermand and Orhan Sezer and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Bouke P. C. Hazenberg

114 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis

2005 992 citations Bouke P. C. Hazenberg, Giampaolo Merlini et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bouke P. C. Hazenberg Netherlands	34	3.3k	966	751	738	698	118	4.6k
Yoshihisa Nojima Japan	40	2.2k 0.7×	618 0.6×	509 0.7×	312 0.4×	428 0.6×	231	6.1k
Arnt V. Kristen Germany	39	3.5k 1.1×	1.2k 1.3×	697 0.9×	473 0.6×	499 0.7×	145	4.6k
Hans J. Baelde Netherlands	41	1.8k 0.6×	1.5k 1.6×	538 0.7×	240 0.3×	737 1.1×	160	5.8k
Yeon S. Ahn United States	44	2.8k 0.9×	428 0.4×	627 0.8×	399 0.5×	543 0.8×	131	6.9k
G. Schernthaner Austria	45	1.4k 0.4×	291 0.3×	786 1.0×	648 0.9×	1.1k 1.6×	251	6.4k
Tammo Ostendorf Germany	44	2.0k 0.6×	2.0k 2.0×	240 0.3×	370 0.5×	287 0.4×	98	5.1k
Pablo García‐Pavía Spain	39	3.0k 0.9×	1.1k 1.1×	655 0.9×	624 0.8×	586 0.8×	244	5.5k
Byron P. Croker United States	41	1.3k 0.4×	763 0.8×	1.4k 1.9×	294 0.4×	433 0.6×	100	5.3k
Keiju Hiromura Japan	29	1.1k 0.3×	1.2k 1.3×	685 0.9×	241 0.3×	219 0.3×	123	3.4k
Wenche Jy United States	41	3.0k 0.9×	253 0.3×	552 0.7×	399 0.5×	478 0.7×	121	6.1k

Countries citing papers authored by Bouke P. C. Hazenberg

Since Specialization

Citations

This map shows the geographic impact of Bouke P. C. Hazenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bouke P. C. Hazenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bouke P. C. Hazenberg more than expected).

Fields of papers citing papers by Bouke P. C. Hazenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bouke P. C. Hazenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bouke P. C. Hazenberg. The network helps show where Bouke P. C. Hazenberg may publish in the future.

Co-authorship network of co-authors of Bouke P. C. Hazenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Bouke P. C. Hazenberg. A scholar is included among the top collaborators of Bouke P. C. Hazenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bouke P. C. Hazenberg. Bouke P. C. Hazenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Groothof, Dion, Johan Bijzet, Ewout J. Houwerzijl, et al.. (2024). [99mTc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients. European Journal of Nuclear Medicine and Molecular Imaging. 52(1). 88–97. 1 indexed citations

Markousis‐Mavrogenis, George, Laura M G Meems, Johan Bijzet, et al.. (2024). Circulating ECM proteins decorin and alpha-L-iduronidase differentiate ATTRwt-CM from ATTRwt-negative HFpEF/HFmrEF. Cardiovascular Research. 120(14). 1727–1736. 4 indexed citations

Bijzet, Johan, Ewout J. Houwerzijl, Friso L. H. Muntinghe, et al.. (2024). High-Sensitivity Cardiac Troponin T to Exclude Cardiac Involvement in TTR Variant Carriers and ATTRv Amyloidosis Patients. Journal of Clinical Medicine. 13(3). 810–810. 2 indexed citations

Nienhuis, Hans, David Adams, Chafic Karam, et al.. (2024). Neurofilament Light Chains in Systemic Amyloidosis: A Systematic Review. International Journal of Molecular Sciences. 25(7). 3770–3770. 7 indexed citations

Nienhuis, Hans, David Adams, Chafic Karam, et al.. (2024). Neurofilament Light Chain in Systemic Amyloidosis: A Systematic Review. Preprints.org. 2 indexed citations

Silvestre, Dario Di, Francesca Brambilla, Francesca Lavatelli, et al.. (2023). The Protein Network in Subcutaneous Fat Biopsies from Patients with AL Amyloidosis: More Than Diagnosis?. Cells. 12(5). 699–699. 6 indexed citations

Baur, Julian, Christoph Daniel, Manuel Hitzenberger, et al.. (2022). Amyloid fibril structure from the vascular variant of systemic AA amyloidosis. Nature Communications. 13(1). 7261–7261. 18 indexed citations

Bijzet, Johan, Wilfried Roeloffzen, Antje Bischof, et al.. (2020). Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis. Amyloid. 28(1). 50–55. 40 indexed citations

Minnema, Monique C., Kazem Nasserinejad, Bouke P. C. Hazenberg, et al.. (2019). Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial. Haematologica. 104(11). 2274–2282. 23 indexed citations

10.

Connolly, Mark P., et al.. (2019). Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis. Orphanet Journal of Rare Diseases. 14(1). 220–220. 13 indexed citations

11.

Liberta, Falk, Sarah Loerch, Angelika Schierhorn, et al.. (2019). Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids. Nature Communications. 10(1). 1104–1104. 110 indexed citations

12.

Treglia, Giorgio, Andor W.J.M. Glaudemans, Francesco Bertagna, et al.. (2018). Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis. European Journal of Nuclear Medicine and Molecular Imaging. 45(11). 1945–1955. 85 indexed citations

13.

Minnema, Monique C., Kazem Nasserinejad, Bouke P. C. Hazenberg, et al.. (2017). HOVON 104; FINAL RESULTS FROM A MULTICENTER, PROSPECTIVE PHASE II STUDY OF BORTEZOMIB BASED INDUCTION TREATMENT FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH DE NOVO AL AMYLOIDOSIS. Data Archiving and Networked Services (DANS). 1 indexed citations

14.

Hazenberg, Bouke P. C., Alexandra Croockewit, Bronno van der Holt, et al.. (2015). Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology. Haematologica. 100(5). 677–682. 16 indexed citations

15.

Bijzet, Johan, et al.. (2011). Lower Serum Paraoxonase-1 Activity Is Related to Higher Serum Amyloid A Levels in Metabolic Syndrome. Archives of Medical Research. 42(3). 219–225. 44 indexed citations

16.

Gameren, Ingrid I. van, et al.. (2009). Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain. Haematologica. 94(8). 1094–1100. 26 indexed citations

17.

Meijer, Jiska, Stefan Schönland, Giovanni Palladini, et al.. (2008). Sjögren's syndrome and localized nodular cutaneous amyloidosis: Coincidence or a distinct clinical entity?. Arthritis & Rheumatism. 58(7). 1992–1999. 44 indexed citations

18.

Altland, Klaus, Merrill D. Benson, Catherine E. Costello, et al.. (2007). Genetic microheterogeneity of human transthyretin detected by IEF. Electrophoresis. 28(12). 2053–2064. 25 indexed citations

19.

Hazenberg, Bouke P. C., Ingrid I. van Gameren, Johan Bijzet, P. L. Jager, & M. H. van Rijswijk. (2004). Diagnostic and therapeutic approach of systemic amyloidosis.. PubMed. 62(4). 121–8. 50 indexed citations

20.

Geerlings, W., et al.. (1994). Annual evaluation of hip joints and hands for radiographic signs of A?2M-amyloidosis in long-term hemodialysis patients. Skeletal Radiology. 23(6). 421–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact